GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ananda Pharma PLC (AQSE:ANA) » Definitions » FCF Margin %

Ananda Pharma (AQSE:ANA) FCF Margin % : 0.00% (As of Jul. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Ananda Pharma FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Ananda Pharma's Free Cash Flow for the six months ended in Jul. 2023 was £0.00 Mil. Ananda Pharma's Revenue for the six months ended in Jul. 2023 was £0.00 Mil. Therefore, Ananda Pharma's FCF Margin % for the quarter that ended in Jul. 2023 was 0.00%.

As of today, Ananda Pharma's current FCF Yield % is 0.00%.

The historical rank and industry rank for Ananda Pharma's FCF Margin % or its related term are showing as below:


AQSE:ANA's FCF Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 0.86
* Ranked among companies with meaningful FCF Margin % only.


Ananda Pharma FCF Margin % Historical Data

The historical data trend for Ananda Pharma's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ananda Pharma FCF Margin % Chart

Ananda Pharma Annual Data
Trend Jan19 Jan20 Jan21 Jan22 Jan23
FCF Margin %
- - - - -

Ananda Pharma Semi-Annual Data
Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Ananda Pharma's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Ananda Pharma's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ananda Pharma's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ananda Pharma's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Ananda Pharma's FCF Margin % falls into.


;
;

Ananda Pharma FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Ananda Pharma's FCF Margin for the fiscal year that ended in Jan. 2023 is calculated as

FCF Margin=Free Cash Flow (A: Jan. 2023 )/Revenue (A: Jan. 2023 )
=-0.457/0
= %

Ananda Pharma's FCF Margin for the quarter that ended in Jul. 2023 is calculated as

FCF Margin=Free Cash Flow (Q: Jul. 2023 )/Revenue (Q: Jul. 2023 )
=0/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ananda Pharma FCF Margin % Related Terms

Thank you for viewing the detailed overview of Ananda Pharma's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Ananda Pharma Business Description

Traded in Other Exchanges
N/A
Address
60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR
Ananda Pharma PLC is focused on the development of cannabinoid therapies for the treatment of a range of complex conditions. The company is developing NHS-approved and MHRA-licensed cannabinoid medicines for the treatment of drug-resistant epilepsies and specific inflammatory pain conditions (starting with CIPN & endometriosis) and HFpEF heart failure.

Ananda Pharma Headlines

No Headlines